Rare
lephants
Screener
Toggle theme
MiMedx Group, Inc.
MDXG
·
Healthcare, Medical Devices, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2018
FY2017
FY2016
FY2015
FY2014
Total Cash from Operations:
$79.6M
Line Item
Value
% of Total
Capital Expenditures
$2.0M
2.5%
Other Investing
$168.0K
0.2%
Stock Repurchases
$9.5M
12.0%
Working Capital
$51.8M
65.2%
Net Cash Flow
$16.1M
20.2%
Download CSV
